-
Health and WellnessA clinical trial for a HIV vaccine has been an overwhelming success
The first phase of the trial was 97 percent successful in “stimulating production of rare immune cells” that are resistant to HIV.
-
News (USA)Could this scientific breakthrough lead to the end of HIV?
For the first time, genes that cause HIV have been edited out by scientists working on lab rats and mice, and researchers hope to someday do the same for humans.
-
News (USA)FDA approves first drug for reducing the risk of sexually acquired HIV
WASHINGTON — The U.S. Food and Drug Administration on Monday approved Truvada, the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection, or who may engage in sexual activity with HIV-infected partners.
